Inception Return
(7/3/2002)
|
5.32 %
|
|
YTD Return
|
5.69 %
|
|
NAVPS
(1/28/2026)
|
$13.33
|
|
Change
|
($0.10) / -0.77 %
|
|
|
Growth of $10,000
(As of December 31, 2025)
|
|
MER
|
2.36 %
|
|
Assets ($mil)
|
$176.76
|
|
Rank (1Yr)
|
1763/2067
|
|
Std Dev (3Yr)
|
15.12 %
|
|
Volatility Ranking (3Yr)
|
7/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Choice of Front or No Load
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
To provide capital appreciation over the medium to longer term. The Fund invests primarily in equity and equity-type securities of multinational companies throughout the world. It may also invest in companies that the portfolio sub-advisors expect will achieve multinational status. Income will not be a prime consideration for securityholders in the Fund. The fundamental investment objective of the Fund cannot be changed without the approval of investors who own securities in the Fund.
|
Fund Manager
Manulife Investment Management Limited
Portfolio Manager
Manulife Investment Management Limited
Sub-Advisor
Jonathan White , Manulife Investment Management (US) LLC
|
|
Asset Allocation
(As of November 30, 2025)
|
Sector Allocation
(As of November 30, 2025)
|
Geographic Allocation
(As of November 30, 2025)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Amazon.com Inc | US Equity | Consumer Services | United States | 8.31% |
| Danone SA | International Equity | Consumer Goods | European Union | 6.09% |
| Elanco Animal Health Inc | US Equity | Healthcare | United States | 5.04% |
| UnitedHealth Group Inc | US Equity | Healthcare | United States | 4.33% |
| Anheuser Busch Inbev SA | International Equity | Consumer Goods | European Union | 4.19% |
| Liberty Media Corp | US Equity | Telecommunications | United States | 3.50% |
| Heineken Holding NV | International Equity | Consumer Goods | European Union | 3.32% |
| Exor NV | International Equity | Consumer Goods | European Union | 3.23% |
| Associated British Foods PLC | International Equity | Consumer Goods | European Union | 2.90% |
| Thermo Fisher Scientific Inc | US Equity | Healthcare | United States | 2.84% |
Performance Data
(As of December 31, 2025)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-0.82
|
-1.69
|
2.90
|
5.69
|
5.69
|
14.40
|
6.70
|
5.25
|
|
Benchmark
|
-0.91
|
1.63
|
11.64
|
16.60
|
16.60
|
20.86
|
12.65
|
11.59
|
|
Quartile Ranking
|
2
|
4
|
4
|
4
|
4
|
3
|
4
|
4
|
|
Calendar Return (%)
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|
Fund
|
5.69
|
17.45
|
20.63
|
-19.77
|
15.13
|
8.87
|
23.84
|
-12.53
|
12.90
|
-9.44
|
|
Benchmark
|
16.60
|
26.84
|
19.37
|
-12.64
|
17.62
|
13.15
|
21.41
|
-1.79
|
16.29
|
5.18
|
|
Quartile Ranking
|
4
|
3
|
1
|
4
|
3
|
3
|
1
|
4
|
3
|
4
|